4Filed Aug 6, 8:00 PM ET

Entera Bio (ENTX) Director Germano Receives Shares and Options

$ENTX · Entera Bio Ltd.

Research Summary

AI-generated summary of this SEC filing

Updated

Entera Bio (ENTX) Director Germano Receives Shares and Options

What Happened
Germano Geno J, a director of Entera Bio Ltd. (ENTX), was awarded compensation in the form of equity on 2026-08-07. The filing shows (1) 25,014 ordinary shares granted (acquired at $0.00) and (2) two option grants covering 50,000 and 43,014 ordinary shares (derivative securities, $0.00). No cash was paid for these awards; the options are grants under the company’s equity plan.

Key Details

  • Transaction date and filing date: 2026-08-07 (Form 4 filing accession 0001178913-26-003949). Transaction code: A = Award/Grant.
  • Grants: 25,014 shares @ $0.00 (acquired); options for 50,000 and 43,014 shares @ $0.00 (derivatives). Aggregate potential shares = 118,028 (25,014 shares + 93,014 option shares).
  • Reported value: $0 cash paid at grant; awards issued in lieu of cash director fees (see F1).
  • Vesting (options):
    • 50,000-option grant (F2): Vesting over 3 years beginning Feb 4, 2026 — one-third vests on Feb 4, 2027; remaining two-thirds vest ratably quarterly over the next two years. Full acceleration upon a Change in Control.
    • 43,014-option grant (F3): Vesting quarterly over a one-year period beginning Feb 4, 2026. Full acceleration upon a Change in Control.
  • Approvals/conditions: Board approved awards Aug 5, 2026; option grants were previously approved by shareholders on July 14, 2026 and became registrable when the company filed a Form S-8 on Aug 7, 2026.
  • Shares owned after transaction: Not specified in the provided filing details.
  • Timeliness: Filing shows transaction and report filed on the same date (no indication of a late filing in the provided data).

Context

  • These transactions are grants/compensation (not open-market purchases or sales). Awards issued in lieu of cash fees are routine director compensation and do not necessarily indicate a bullish or bearish signal by the insider.
  • The option grants are derivative awards that vest over time; they do not represent immediately tradeable shares until vested (and then subject to exercise).